BofA Reiterates Hold Rating on Novavax (NVAX) Stock

finance.yahoo.com/news/bofa-reiterates-hold-rating-novavax-173025978.html

In This Article:
On May 20, BofA analyst Alec Stranahan reiterated a Hold rating on Novavax, Inc. (NASDAQ:NVAX) stock, setting a price target of $10.
The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from Sanofi during…

This story appeared on finance.yahoo.com, 2025-05-21 17:30:25.
The Entire Business World on a Single Page. Free to Use →